Dr D'Abreo on Patient Consideration When Choosing Treatments in HER2+ Breast Cancer
January 19th 2024Nina D'Abreo, MD, discusses the importance of considering a patient’s medical history and preferences when deciding on a treatment course in HER2-positive breast cancer and highlights the important role of surgeons within breast cancer treatment.
Dr Novik on Emergent Treatment Options in ER+ Breast Cancer
January 8th 2024Yelena Novik, MD, discusses advancements and emerging trends that have been seen in the treatment of patients with advanced estrogen-receptor–positive breast cancer, citing clinical trials that have helped push the treatment armamentarium forward.
Simeone and Fakih Detail Research Objectives With A2B530 in CEA-Expressing Solid Tumors
December 18th 2023Drs Simeone and Fakih discuss the main objective and design of the observational BASECAMP-1 study and how it functions alongside the EVEREST-1 study, which is evaluating the autologous CAR T-cell therapy A2B530 in patients with CEA-expressing solid tumors that have lost HLA-A*02 expression.
Diversity and Access to Clinical Trials in Endometrial Cancer
December 4th 2023Experts Ritu Salani, MD, MBA, and Bhavana Pothuri, MD, explore the significance of enrolling diverse patients in clinical trials and the pivotal role of community settings in advancing endometrial cancer research and treatment.